Ureteral Access Sheath Market
Description
Size, Share, & Trends Analysis Report By Product Type (Standard (Single-Lumen), Reinforced, Dual‑Lumen), By Clinical Indication (Stone Management), By Age Group, By Size, By End Use (Hospitals, Specialty Clinics, Diagnostic Centers), And Segment Forecasts, 2026 - 2033
Ureteral Access Sheath Market Summary
The global ureteral access sheath market size was valued at USD 609.56 million in 2025 and is projected to reach USD 1,068.85 million by 2033, growing at a CAGR of 7.18% from 2026 to 2033. The ureteral access sheath market is primarily driven by the rising prevalence of urolithiasis and other urological disorders, which have increased the volume of ureteroscopy procedures globally.
The growing adoption of minimally invasive surgeries, coupled with technological advancements that improve procedural efficiency, safety, and reduce operative time, is further accelerating market growth. According to the National Kidney Foundation, more than 500,000 people visit emergency rooms each year due to kidney stones, highlighting the significant clinical burden of the condition. In nearly 1 in 10 individuals, a kidney stone is expected to develop at some point during their lifetime. The rising prevalence of urolithiasis is a key driver of growth in the ureteral access sheath market, as increasing stone cases directly increase the number of ureteroscopic procedures. Ureteral access sheaths are essential in stone management, enabling efficient scope exchanges and improved intrarenal pressure control. As kidney stone incidence continues to grow due to lifestyle and dietary changes, demand for advanced ureteral access devices is expected to increase significantly. According to the
National Kidney Foundation, in 2025, approximately 1 in 10 people have experienced a kidney stone at some point in their lives. The condition is slightly more common among men, with about 11 out of every 100 affected, compared to around 9 out of every 100 women.
The growing adoption of minimally invasive urological procedures is a key driver of the ureteral access sheath market, as these procedures depend on safe, efficient ureteral access. Procedures such as ureteroscopy, retrograde intrarenal surgery (RIRS), and laser lithotripsy use access sheaths to facilitate smooth instrument exchange and improve intrarenal pressure control. The shift toward shorter hospital stays, reduced complications, and faster recovery continues to accelerate demand for ureteral access sheaths.
For instance, a 2025 study published in the Journal of Urological Surgery compared the impact of multiple sessions of retrograde intrarenal surgery (RIRS) with single-access conventional percutaneous nephrolithotomy (PCNL) on acute kidney injury (AKI) in patients with nephrolithiasis. The retrospective analysis included patients who underwent multiple RIRS procedures within three months in the same renal unit and those who received single-access PCNL between January 2018 and December 2023.
Global Ureteral Access Sheath Market Report Segmentation
This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the ureteral access sheath market report on the basis of product type, size, age group, clinical indication, end use and region:
Ureteral Access Sheath Market Summary
The global ureteral access sheath market size was valued at USD 609.56 million in 2025 and is projected to reach USD 1,068.85 million by 2033, growing at a CAGR of 7.18% from 2026 to 2033. The ureteral access sheath market is primarily driven by the rising prevalence of urolithiasis and other urological disorders, which have increased the volume of ureteroscopy procedures globally.
The growing adoption of minimally invasive surgeries, coupled with technological advancements that improve procedural efficiency, safety, and reduce operative time, is further accelerating market growth. According to the National Kidney Foundation, more than 500,000 people visit emergency rooms each year due to kidney stones, highlighting the significant clinical burden of the condition. In nearly 1 in 10 individuals, a kidney stone is expected to develop at some point during their lifetime. The rising prevalence of urolithiasis is a key driver of growth in the ureteral access sheath market, as increasing stone cases directly increase the number of ureteroscopic procedures. Ureteral access sheaths are essential in stone management, enabling efficient scope exchanges and improved intrarenal pressure control. As kidney stone incidence continues to grow due to lifestyle and dietary changes, demand for advanced ureteral access devices is expected to increase significantly. According to the
National Kidney Foundation, in 2025, approximately 1 in 10 people have experienced a kidney stone at some point in their lives. The condition is slightly more common among men, with about 11 out of every 100 affected, compared to around 9 out of every 100 women.
The growing adoption of minimally invasive urological procedures is a key driver of the ureteral access sheath market, as these procedures depend on safe, efficient ureteral access. Procedures such as ureteroscopy, retrograde intrarenal surgery (RIRS), and laser lithotripsy use access sheaths to facilitate smooth instrument exchange and improve intrarenal pressure control. The shift toward shorter hospital stays, reduced complications, and faster recovery continues to accelerate demand for ureteral access sheaths.
For instance, a 2025 study published in the Journal of Urological Surgery compared the impact of multiple sessions of retrograde intrarenal surgery (RIRS) with single-access conventional percutaneous nephrolithotomy (PCNL) on acute kidney injury (AKI) in patients with nephrolithiasis. The retrospective analysis included patients who underwent multiple RIRS procedures within three months in the same renal unit and those who received single-access PCNL between January 2018 and December 2023.
Global Ureteral Access Sheath Market Report Segmentation
This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the ureteral access sheath market report on the basis of product type, size, age group, clinical indication, end use and region:
- Product Type Outlook (Revenue, USD Million, 2021 - 2033)
- Standard (Single-Lumen)
- Reinforced
- Dual Lumen
- Size Outlook (Revenue, USD Million, 2021 - 2033)
- <10
- 10 to 12
- More than or equal to 13 - 15
- Age Group Outlook (Revenue, USD Million, 2021 - 2033)
- Adult
- Pediatric
- Clinical Indication Outlook (Revenue, USD Million, 2021 - 2033)
- Stone Management
- Others
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals
- Specialty Clinics
- Diagnostic Centers
- ASCs
- Others
- Region Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
150 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Segment Definitions
- 1.2.1. Product Type
- 1.2.2. Size
- 1.2.3. Clinical Indication
- 1.2.4. Age Group
- 1.2.5. End Use
- 1.2.6. Regional scope
- 1.2.7. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR’s internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Regional outlook
- 2.4. Competitive Insights
- Chapter 3. Ureteral Access Sheath Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Rising prevalence of urolithiasis
- 3.2.1.2. Growing adoption of minimally invasive urological procedures
- 3.2.1.3. Technological advancements
- 3.2.1.4. Increasing procedural volumes in outpatient and ambulatory surgical centers
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High cost of advanced ureteral access sheaths
- 3.2.2.2. Availability of alternative techniques
- 3.2.3. Market Opportunity Analysis
- 3.2.3.1. Expanding healthcare infrastructure in emerging economies
- 3.2.3.2. Growing adoption of advanced design
- 3.2.3.3. Shift toward single-use and disposable devices
- 3.2.4. Market Challenge Analysis
- 3.2.4.1. Regulatory and quality compliance requirements
- 3.2.4.2. Pricing pressure from hospitals and group purchasing organizations
- 3.3. Ureteral Access Sheath Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Technological landscape
- 3.3.2.5. Environmental landscape
- 3.3.2.6. Legal landscape
- Chapter 4. Ureteral Access Sheath Market: Product Type Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Ureteral Access Sheath Market: Product Type Movement Analysis
- 4.3. Ureteral Access Sheath Market by Product Type Outlook (USD Million)
- 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 4.5. Standard (Single-Lumen)
- 4.5.1. Standard (Single-Lumen) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6. Reinforced
- 4.6.1. Reinforced Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.7. Dual‑Lumen
- 4.7.1. Dual‑Lumen Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 5. Ureteral Access Sheath Market: Size Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Ureteral Access Sheath Market: Size Movement Analysis
- 5.3. Ureteral Access Sheath Market by Size Outlook (USD Million)
- 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 5.5. <10
- 5.5.1. <10 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6. 10 to 12
- 5.6.1. 10 to 12 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.7. More than or equal to 13 - 15
- 5.7.1. More than or equal to 13 - 15 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 6. Ureteral Access Sheath Market: Age Group Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Ureteral Access Sheath Market: Age Group Movement Analysis
- 6.3. Ureteral Access Sheath Market by Age Group Outlook (USD Million)
- 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 6.5. Adult
- 6.5.1. Adult Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6. Pediatric
- 6.6.1. Pediatric Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 7. Ureteral Access Sheath Market: Clinical Indication Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Ureteral Access Sheath Market: Clinical Indication Movement Analysis
- 7.3. Ureteral Access Sheath Market by Clinical Indication Outlook (USD Million)
- 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 7.5. Stone Management
- 7.5.1. Stone Management Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6. Others
- 7.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 8. Ureteral Access Sheath Market: End Use Estimates & Trend Analysis
- 8.1. Segment Dashboard
- 8.2. Ureteral Access Sheath Market: End Use Movement Analysis
- 8.3. Ureteral Access Sheath Market by End Use Outlook (USD Million)
- 8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 8.5. Hospitals
- 8.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6. Specialty Clinics
- 8.6.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.7. Diagnostic Centers
- 8.7.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.8. Ambulatory Surgery Centers (ASCs)
- 8.8.1. Ambulatory Surgery Centers (ASCs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.9. Others
- 8.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 9. Ureteral Access Sheath Market: Regional Estimates & Trend Analysis
- 9.1. Regional Dashboard
- 9.2. Regional Ureteral Access Sheath Market Movement Analysis & Market Share, 2025 & 2033
- 9.3. Ureteral Access Sheath Market: Regional Estimates & Trend Analysis
- 9.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 9.5. North America
- 9.5.1. North America Ureteral Access Sheath Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.2. U.S.
- 9.5.2.1. Key Country Dynamics
- 9.5.2.2. Competitive Scenario
- 9.5.2.3. Regulatory Framework
- 9.5.2.4. Reimbursement scenario
- 9.5.2.5. U.S. Ureteral Access Sheath Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.3. Canada
- 9.5.3.1. Key Country Dynamics
- 9.5.3.2. Competitive Scenario
- 9.5.3.3. Regulatory Framework
- 9.5.3.4. Reimbursement scenario
- 9.5.3.5. Canada Ureteral Access Sheath Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.4. Mexico
- 9.5.4.1. Key Country Dynamics
- 9.5.4.2. Competitive Scenario
- 9.5.4.3. Regulatory Framework
- 9.5.4.4. Reimbursement scenario
- 9.5.4.5. Mexico Ureteral Access Sheath Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.5. Europe
- 9.5.6. Europe Ureteral Access Sheath Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.7. UK
- 9.5.7.1. Key Country Dynamics
- 9.5.7.2. Competitive Scenario
- 9.5.7.3. Regulatory Framework
- 9.5.7.4. Reimbursement scenario
- 9.5.7.5. UK Ureteral Access Sheath Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.8. Germany
- 9.5.8.1. Key Country Dynamics
- 9.5.8.2. Competitive Scenario
- 9.5.8.3. Regulatory Framework
- 9.5.8.4. Reimbursement scenario
- 9.5.8.5. Germany Ureteral Access Sheath Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.9. France
- 9.5.9.1. Key Country Dynamics
- 9.5.9.2. Competitive Scenario
- 9.5.9.3. Regulatory Framework
- 9.5.9.4. Reimbursement scenario
- 9.5.9.5. France Ureteral Access Sheath Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.10. Italy
- 9.5.10.1. Key Country Dynamics
- 9.5.10.2. Competitive Scenario
- 9.5.10.3. Regulatory Framework
- 9.5.10.4. Reimbursement scenario
- 9.5.10.5. Italy Ureteral Access Sheath Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.11. Spain
- 9.5.11.1. Key Country Dynamics
- 9.5.11.2. Competitive Scenario
- 9.5.11.3. Regulatory Framework
- 9.5.11.4. Reimbursement scenario
- 9.5.11.5. Spain Ureteral Access Sheath Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.12. Denmark
- 9.5.12.1. Key Country Dynamics
- 9.5.12.2. Competitive Scenario
- 9.5.12.3. Regulatory Framework
- 9.5.12.4. Reimbursement scenario
- 9.5.12.5. Denmark Ureteral Access Sheath Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.13. Sweden
- 9.5.13.1. Key Country Dynamics
- 9.5.13.2. Competitive Scenario
- 9.5.13.3. Regulatory Framework
- 9.5.13.4. Reimbursement scenario
- 9.5.13.5. Sweden Ureteral Access Sheath Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.14. Norway
- 9.5.14.1. Key Country Dynamics
- 9.5.14.2. Competitive Scenario
- 9.5.14.3. Regulatory Framework
- 9.5.14.4. Reimbursement scenario
- 9.5.14.5. Norway Ureteral Access Sheath Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.6. Asia Pacific
- 9.6.1. Asia Pacific Ureteral Access Sheath Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.6.2. Japan
- 9.6.2.1. Key Country Dynamics
- 9.6.2.2. Competitive Scenario
- 9.6.2.3. Regulatory Framework
- 9.6.2.4. Reimbursement scenario
- 9.6.2.5. Japan Ureteral Access Sheath Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.6.3. China
- 9.6.3.1. Key Country Dynamics
- 9.6.3.2. Competitive Scenario
- 9.6.3.3. Regulatory Framework
- 9.6.3.4. Reimbursement scenario
- 9.6.3.5. China Ureteral Access Sheath Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.6.4. India
- 9.6.4.1. Key Country Dynamics
- 9.6.4.2. Competitive Scenario
- 9.6.4.3. Regulatory Framework
- 9.6.4.4. Reimbursement scenario
- 9.6.4.5. India Ureteral Access Sheath Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.6.5. South Korea
- 9.6.5.1. Key Country Dynamics
- 9.6.5.2. Competitive Scenario
- 9.6.5.3. Regulatory Framework
- 9.6.5.4. Reimbursement scenario
- 9.6.5.5. South Korea Ureteral Access Sheath Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.6.6. Australia
- 9.6.6.1. Key Country Dynamics
- 9.6.6.2. Competitive Scenario
- 9.6.6.3. Regulatory Framework
- 9.6.6.4. Reimbursement scenario
- 9.6.6.5. Australia Ureteral Access Sheath Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.6.7. Thailand
- 9.6.7.1. Key Country Dynamics
- 9.6.7.2. Competitive Scenario
- 9.6.7.3. Regulatory Framework
- 9.6.7.4. Reimbursement scenario
- 9.6.7.5. Thailand Ureteral Access Sheath Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.7. Latin America
- 9.7.1. Latin America Ureteral Access Sheath Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.7.2. Brazil
- 9.7.2.1. Key Country Dynamics
- 9.7.2.2. Competitive Scenario
- 9.7.2.3. Regulatory Framework
- 9.7.2.4. Reimbursement scenario
- 9.7.2.5. Brazil Ureteral Access Sheath Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.7.3. Argentina
- 9.7.3.1. Key Country Dynamics
- 9.7.3.2. Competitive Scenario
- 9.7.3.3. Regulatory Framework
- 9.7.3.4. Reimbursement scenario
- 9.7.3.5. Argentina Ureteral Access Sheath Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.8. Middle East & Africa
- 9.8.1. Middle East & Africa Ureteral Access Sheath Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.8.2. South Africa
- 9.8.2.1. Key Country Dynamics
- 9.8.2.2. Competitive Scenario
- 9.8.2.3. Regulatory Framework
- 9.8.2.4. Reimbursement scenario
- 9.8.2.5. South Africa Ureteral Access Sheath Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.8.3. Saudi Arabia
- 9.8.3.1. Key Country Dynamics
- 9.8.3.2. Competitive Scenario
- 9.8.3.3. Regulatory Framework
- 9.8.3.4. Reimbursement scenario
- 9.8.3.5. Saudi Arabia Ureteral Access Sheath Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.8.4. UAE
- 9.8.4.1. Key Country Dynamics
- 9.8.4.2. Competitive Scenario
- 9.8.4.3. Regulatory Framework
- 9.8.4.4. Reimbursement scenario
- 9.8.4.5. UAE Ureteral Access Sheath Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.8.5. Kuwait
- 9.8.5.1. Key Country Dynamics
- 9.8.5.2. Competitive Scenario
- 9.8.5.3. Regulatory Framework
- 9.8.5.4. Reimbursement scenario
- 9.8.5.5. Kuwait Ureteral Access Sheath Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 10. Competitive Landscape
- 10.1. Market Participant Categorization
- 10.2. Company Shre Analysis, 2025
- 10.3. Key Company Profiles
- 10.3.1. Boston Scientific Corporation
- 10.3.1.1. Company overview
- 10.3.1.2. Financial performance
- 10.3.1.3. Product benchmarking
- 10.3.1.4. Strategic initiatives
- 10.3.2. BD
- 10.3.2.1. Company overview
- 10.3.2.2. Financial performance
- 10.3.2.3. Product benchmarking
- 10.3.2.4. Strategic initiatives
- 10.3.3. Olympus
- 10.3.3.1. Company overview
- 10.3.3.2. Financial performance
- 10.3.3.3. Product benchmarking
- 10.3.3.4. Strategic initiatives
- 10.3.4. Coloplast
- 10.3.4.1. Company overview
- 10.3.4.2. Financial performance
- 10.3.4.3. Product benchmarking
- 10.3.4.4. Strategic initiatives
- 10.3.5. Cook Medical
- 10.3.5.1. Company overview
- 10.3.5.2. Financial performance
- 10.3.5.3. Product benchmarking
- 10.3.5.4. Strategic initiatives
- 10.3.6. Advin Health Care
- 10.3.6.1. Company overview
- 10.3.6.2. Financial performance
- 10.3.6.3. Product benchmarking
- 10.3.6.4. Strategic initiatives
- 10.3.7. Judges Scientific plc (GEOTEK)
- 10.3.7.1. Company overview
- 10.3.7.2. Financial performance
- 10.3.7.3. Product benchmarking
- 10.3.7.4. Strategic initiatives
- 10.3.8. ACE Medical Devices
- 10.3.8.1. Company overview
- 10.3.8.2. Financial performance
- 10.3.8.3. Product benchmarking
- 10.3.8.4. Strategic initiatives
- 10.3.9. Blue Neem Medical Devices Private Limited
- 10.3.9.1. Company overview
- 10.3.9.2. Financial performance
- 10.3.9.3. Product benchmarking
- 10.3.9.4. Strategic initiatives
- 10.3.10. AMECATH
- 10.3.10.1. Company overview
- 10.3.10.2. Financial performance
- 10.3.10.3. Product benchmarking
- 10.3.10.4. Strategic initiatives
- 10.3.11. Creo Medical
- 10.3.11.1. Company overview
- 10.3.11.2. Financial performance
- 10.3.11.3. Product benchmarking
- 10.3.11.4. Strategic initiatives
- 10.3.12. Applied Medical Resources Corporation
- 10.3.12.1. Company overview
- 10.3.12.2. Financial performance
- 10.3.12.3. Product benchmarking
- 10.3.12.4. Strategic initiatives
- 10.3.13. Volkmann Medizintechnik Gmbh.
- 10.3.13.1. Company overview
- 10.3.13.2. Financial performance
- 10.3.13.3. Product benchmarking
- 10.3.13.4. Strategic initiatives
- 10.3.14. Urovision-Urotech
- 10.3.14.1. Company overview
- 10.3.14.2. Financial performance
- 10.3.14.3. Product benchmarking
- 10.3.14.4. Strategic initiatives
- 10.3.15. Rocamed SAM
- 10.3.15.1. Company overview
- 10.3.15.2. Financial performance
- 10.3.15.3. Product benchmarking
- 10.3.15.4. Strategic initiatives
- 10.3.16. Well Lead Medical Co.,Ltd.
- 10.3.16.1. Company overview
- 10.3.16.2. Financial performance
- 10.3.16.3. Product benchmarking
- 10.3.16.4. Strategic initiatives
- 10.3.17. Richard Wolf GmbH
- 10.3.17.1. Company overview
- 10.3.17.2. Financial performance
- 10.3.17.3. Product benchmarking
- 10.3.17.4. Strategic initiatives
- 10.3.18. SCW Medicath Ltd
- 10.3.18.1. Company overview
- 10.3.18.2. Financial performance
- 10.3.18.3. Product benchmarking
- 10.3.18.4. Strategic initiatives
- 10.3.19. Innovex Medical
- 10.3.19.1. Company overview
- 10.3.19.2. Financial performance
- 10.3.19.3. Product benchmarking
- 10.3.19.4. Strategic initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
